18.11.2012 Views

Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK

Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK

Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Daily ur<strong>in</strong>ary excretion [Bqd -1 ]<br />

1E+0<br />

1E-1<br />

1E-2<br />

1E-3<br />

1E-4<br />

Measurements for 239Pu+240Pu<br />

239 Pu+ 240 Pu<br />

Model predictions for 239Pu+240Pu<br />

239 Pu+ 240 Pu<br />

Measurements for 238Pu<br />

238 Pu<br />

Model predictions for 238Pu<br />

238 Pu<br />

1 10 100 1000 10000 100000<br />

Days post <strong>in</strong>take<br />

Figure 3.2.6 Measurements and model predictions for Americium activity excreted <strong>in</strong> ur<strong>in</strong>e<br />

for the Scenario 3 of contam<strong>in</strong>ation (see Table 3.2.1).<br />

Model’s predictions for the ur<strong>in</strong>ary excretion of <strong>Plutonium</strong> were also evaluated for the<br />

same previous scenarios. The <strong>in</strong>takes calculated on the basis of the Americium activity<br />

reta<strong>in</strong>ed <strong>in</strong> the lungs were multiplied by the model’s predictions for the ur<strong>in</strong>ary excretion per<br />

unit of <strong>in</strong>take (e u(t)). The result<strong>in</strong>g values are presented with the available measurements for<br />

comparison purposes <strong>in</strong> Figure 3.2.4, Figure 3.2.5 and Figure 3.2.6 for the scenarios of<br />

contam<strong>in</strong>ation number 1, 2 and 3, respectively (Table 3.2.1).<br />

Model’s predictions for Americium <strong>in</strong> the lungs and the ur<strong>in</strong>ary excretion of<br />

<strong>Plutonium</strong> clearly po<strong>in</strong>t out that the basic assumption characteriz<strong>in</strong>g the scenario 2 of the<br />

contam<strong>in</strong>ation (absorption type M for <strong>Plutonium</strong>) is not realistic. The predicted Americium<br />

retention <strong>in</strong> lungs considerably underestimates the experimental data already after 100 days<br />

post <strong>in</strong>take (Figure 3.2.2). Furthermore the <strong>in</strong>take evaluated from Americium lung retention<br />

data at short time (for which model’s predictions are still good) determ<strong>in</strong>e a model’s ur<strong>in</strong>ary<br />

excretion of <strong>Plutonium</strong> <strong>in</strong> disagreement with the relat<strong>in</strong>g experimental f<strong>in</strong>d<strong>in</strong>gs (Figure 3.2.5).<br />

Therefore such scenario of contam<strong>in</strong>ation was not considered anymore and all the attention<br />

was then focalised on the scenarios 1 and 3.<br />

From the plots relat<strong>in</strong>g to the Americium burden <strong>in</strong> the lungs it can be po<strong>in</strong>ted out that<br />

the reta<strong>in</strong>ed activity at short time (up to about 100 days post <strong>in</strong>take) is ma<strong>in</strong>ly due to directly<br />

<strong>in</strong>haled Americium. On the contrary, at long time, the activity <strong>in</strong> lungs is ma<strong>in</strong>ly due to the<br />

Americium <strong>in</strong>growth from 241 Pu decay. For both the scenarios 1 and 3 model’s predictions for<br />

the Americium lung retention at short time and the ur<strong>in</strong>ary excretion of <strong>Plutonium</strong> up to 2,000<br />

days post <strong>in</strong>take fit the experimental f<strong>in</strong>d<strong>in</strong>gs. Therefore the assumptions on the absorption<br />

type for the <strong>Plutonium</strong> (type S) and for the Americium directly <strong>in</strong>haled (type M), common to<br />

both scenarios, seems to be appropriate. It should be po<strong>in</strong>ted out that only the <strong>Plutonium</strong><br />

143

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!